Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1992-10-15
|
| pubmed:abstractText |
Data from efficacy trials can provide evidence for the Improvement in Medical Service provided by a drug. A critical analysis of protocols already carried out with a drug enables: a) an evaluation of the limiting characteristics of patients suited to the drug and b) its possible side effects which can be extrapolated to its use in the general population where its use will be much less supervised. An analysis of trial results gives relevant information on the future use and usefulness of the drug.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0040-5957
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
47
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
17-9
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
[Contribution of data of efficacy trials to judge the improvement of the medical usefulness of a drug].
|
| pubmed:affiliation |
INSERM U21, Villejuif.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|